Joseph Stringer
Stock Analyst at Needham
(4.56)
# 237
Out of 5,090 analysts
323
Total ratings
48.77%
Success rate
37.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Downgrades: Hold | n/a | $220.36 | - | 17 | Nov 14, 2025 | |
| GILD Gilead Sciences | Maintains: Buy | $133 → $140 | $121.22 | +15.49% | 9 | Nov 13, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $122 → $120 | $104.60 | +14.72% | 27 | Nov 7, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $78 → $90 | $81.68 | +10.19% | 25 | Oct 30, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $65 | $71.63 | -9.26% | 19 | Oct 27, 2025 | |
| MRNA Moderna | Reiterates: Hold | n/a | $27.70 | - | 9 | Oct 20, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $22 → $35 | $30.87 | +13.38% | 24 | Oct 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $377 → $478 | $458.12 | +4.34% | 23 | Jul 31, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $28 | $14.58 | +92.04% | 52 | Jun 6, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $14 | $6.50 | +115.38% | 18 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $11 | $4.61 | +138.61% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $29 | $23.63 | +22.73% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $455.48 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $46.48 | +93.63% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.40 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.21 | +726.45% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $27.44 | +34.84% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $18.55 | -2.96% | 2 | Aug 24, 2021 |
Cidara Therapeutics
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $220.36
Upside: -
Gilead Sciences
Nov 13, 2025
Maintains: Buy
Price Target: $133 → $140
Current: $121.22
Upside: +15.49%
Rhythm Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $122 → $120
Current: $104.60
Upside: +14.72%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $78 → $90
Current: $81.68
Upside: +10.19%
Avidity Biosciences
Oct 27, 2025
Downgrades: Hold
Price Target: $65
Current: $71.63
Upside: -9.26%
Moderna
Oct 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $27.70
Upside: -
Stoke Therapeutics
Oct 10, 2025
Maintains: Buy
Price Target: $22 → $35
Current: $30.87
Upside: +13.38%
Alnylam Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $377 → $478
Current: $458.12
Upside: +4.34%
Phathom Pharmaceuticals
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $14.58
Upside: +92.04%
Vir Biotechnology
May 22, 2025
Reiterates: Buy
Price Target: $14
Current: $6.50
Upside: +115.38%
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $4.61
Upside: +138.61%
May 7, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $23.63
Upside: +22.73%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $455.48
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $46.48
Upside: +93.63%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.40
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.21
Upside: +726.45%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $27.44
Upside: +34.84%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $18.55
Upside: -2.96%